GS-441524 prodrug (Gilead)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameGS-441524 prodrug (Gilead)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives

Mechanisms of ActionBacterial DNA-directed RNA polymerase modulators

TargetsBacterial DNA-directed RNA polymerase

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGilead Sciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

ATC CodeN/A